Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02654704 · ClinicalTrials.gov registry record
Vaccination Responses in Young and Older Adults
A clinical trial, sponsored by Michigan State University.
- Terminated
- Registry status
- 61
- Enrollment target
NCT02654704 is a clinical trial that was terminated before completion, run by Michigan State University. The registered enrollment target is 61 participants.
The verdict
NCT02654704 was terminated before completion, sponsored by Michigan State University.
- TERMINATED
- Registry status
- 61 participants
- Enrollment target
Study Summary
To follow longitudinally healthy and immune-compromised responses to pneumococcal vaccination, in 60+ individuals towards the development of personalized medicine implementation (minimum enrollments in 2 age categories: young adults\[18-25\], older adults \[55+\], within each category: 10+ healthy, 10+ asthma, 10+ immune-compromised \[e.g. leukemia or autoimmune disorders\]). The approach will profile thousands of molecular components utilizing high-throughput technologies and integrate these data to obtain personalized immune response to vaccination. The study will provide insights into immune response mechanisms specific to asthmatics, immune compromised and healthy individuals, as well as in response to vaccination. Additionally the differences in dynamic response across the two age groups will be investigated.
Interventions
- BIOLOGICAL Pneumococcal Vaccination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2015-11 |
| Est. Completion | 2020-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02654704
The ClinicalTrials.gov registry entry for NCT02654704 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pneumococcal Vaccination is the first listed.
NCT02654704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02654704 about?
NCT02654704 is a clinical study titled "Vaccination Responses in Young and Older Adults". To follow longitudinally healthy and immune-compromised responses to pneumococcal vaccination, in 60+ individuals towards the development of personalized medicine implementation (minimum enrollments in 2 age categories: young adults\[18-25\], older adults \[55+\], within each category: 10+ healthy, ...
What is the current status of trial NCT02654704?
This trial is currently terminated. The enrollment target is 61 participants. The study started on 2015-11. Estimated completion is 2020-07.
What interventions are being tested in trial NCT02654704?
The interventions under investigation include: Pneumococcal Vaccination (BIOLOGICAL).
Who is sponsoring clinical trial NCT02654704?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.